Clinical Pilates' Impact on Fitness, Symptoms & Kinesiophobia in PMS
The Effects of Clinical Pilates on Physical Fitness Parameters, Symptom Severity, and Kinesiophobia in Women With Premenstrual Syndrome.
1 other identifier
interventional
40
1 country
2
Brief Summary
Premenstrual syndrome (PMS) is characterized by a series of somatic and psychological symptoms of varying severity that occur during the luteal phase of the menstrual cycle, affecting approximately 30% of women and resolving with menstruation. These symptoms impact daily activities, interpersonal relationships, social engagements, work efficiency, and educational productivity. PMS manifests with physical symptoms such as breast swelling and tenderness, fatigue, headaches, and weight gain, as well as psychological and emotional symptoms such as mood disorders, irritability, and stress. Symptoms typically subside with the onset of menstruation. There is no single accepted treatment for PMS. Due to conflicting findings in studies, various treatment methods are used, including lifestyle modifications, education, stress management techniques (such as massage, reflexology, and yoga), exercise, or medical support. Regular exercise is known to improve overall well-being. It prevents the decrease in endorphin secretion during the luteal phase of the menstrual cycle and has a positive impact on PMS symptoms, particularly mood disorders, fluid retention, and breast tenderness. Pilates-based exercise training is an approach that enhances muscle stability through effective, controlled movements while strengthening muscle groups associated with pain. Clinical Pilates-based exercise training is considered a preferable method for PMS management, as it is believed to improve functional capacity, pain management, mood disorders, endurance, flexibility, symptom severity, and fear of movement in individuals with PMS. Due to the limited number of studies in the literature on PMS, our study aims to investigate the effects of a clinical Pilates-based exercise program on functional fitness parameters, symptom severity, and kinesiophobia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 4, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2025
CompletedFirst Submitted
Initial submission to the registry
February 10, 2025
CompletedFirst Posted
Study publicly available on registry
February 19, 2025
CompletedFebruary 19, 2025
February 1, 2025
10 months
February 10, 2025
February 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (11)
Body Composition (Waist Circumference)
-Waist Circumference: Measured in centimeters using a non-elastic measuring tape at the narrowest point between the lowest rib and the anterior superior iliac spine (ASIS). It was recorded in centimeters.
8 weeks
Body Composition (Hip Circumference)
-Hip Circumference: Measured in centimeters at the widest part of the gluteus maximus and at the level of the pubis using a measuring tape.
8 weeks
Body Composition (Waist-to-Hip Ratio)
It is calculated by dividing the circumference of the waist by the circumference of the hips.
8 weeks
Functional Capacity
To analyze the participants' functional capacity, the 6-Minute Walk Test (6MWT) was conducted in accordance with the American Thoracic Society (ATS) criteria. In this test, participants were instructed to walk at their own pace without running for six minutes along a 30-meter straight corridor. Standardized encouragement phrases were used throughout the test to maintain motivation. The test result was recorded as the total distance walked in meters.
8 weeks
Flexibility
The Sit and Reach Test is a simple and widely used test to measure the flexibility. For the measurement, a test bench was used with the following dimensions: 32 cm in height, 35 cm in length, and 45 cm in width. A 0-50 cm measurement ruler was placed on the upper surface of the bench, extending 15 cm beyond the edge where the participants' feet were positioned. Participants were seated on the floor with their bare feet extended straight towards the test bench. The measurement was taken at the farthest point reached, where they held the position for 2 seconds. Measure the distance reached in centimeters.
8 weeks
Endurance (Trunk Flexion Test)
The Trunk Flexion Endurance Test measures core muscle endurance, especially in the abdominals and lower back. The person sits with knees bent, leans back to 60 degrees, and holds the position as long as possible. The test stops when the person loses form or falls backward and records in seconds.
8 weeks
Endurance (Lateral Bridge Test)
The Lateral Bridge Test measures core and lateral trunk muscle endurance, especially the obliques. The person holds a side plank position with the body straight and hips lifted. The test ends when the hips drop or the person loses form and records in seconds..
8 weeks
Endurance (Modified Biering-Sorensen Test)
The Modified Biering-Sorensen Test measures endurance of the lower back extensor muscles. The person lies prone on a bench, with the upper body unsupported beyond the edge and legs secured. They hold a horizontal position for as long as possible. The test stops when the person can no longer maintain the position and records in seconds.
8 weeks
Endurance (Prone Bridge Test)
The Prone Bridge Test (Plank Endurance Test) measures core stability and endurance, focusing on the abdominals, lower back, and shoulders. The person holds a forearm plank position, keeping the body straight and avoiding sagging or lifting the hips. The test ends when the person can no longer maintain proper form and records in seconds.
8 weeks
Premenstrual Syndrome Scale
The Premenstrual Syndrome Scale consists of 44 questions and is a five-point Likert-type assessment tool with the following response options: 1. \- Never 2. \- Very little 3. \- Sometimes 4. \- Often 5. \- Always During the administration of the Premenstrual Syndrome Scale, participants were instructed to evaluate each item according to the period one week before menstruation, following the guidelines at the beginning of the scale. They were asked to mark the corresponding rating for each statement based on their experiences during this period.
8 weeks
Tampa Scale for Kinesiophobia
The Tampa Scale for Kinesiophobia is a 17-item questionnaire designed to measure the fear of movement and re-injury. It uses a 4-point Likert scale, with the following response options: 1. \- Strongly disagree 2. \- Disagree 3. \- Agree 4. \- Strongly agree A higher score on the scale indicates a greater level of kinesiophobia (fear of movement and re-injury).
8 weeks
Study Arms (2)
Clinical Pilates Group
EXPERIMENTALControl Group
ACTIVE COMPARATORInterventions
* Wear comfortable clothing and lie on your back. Place one hand on your abdomen. As you inhale through your nose, direct your breath towards your hand, and exhale through your mouth. * In the same position, place one hand on your abdomen, inhale through your nose, and expand your belly under your hand. As you exhale through your mouth, purse your lips and blow out the air from your lungs. * Engage in brisk walking at least three times a week. * Perform stretching exercises similar to yoga; try forward bends while standing and sitting. * Stay active throughout the month; you can dance, swim, or ride a bike. * Reduce your intake of tea and caffeine. * Increase your consumption of milk. * Drink plenty of water. * Reduce your intake of sugar-rich snacks such as chocolate. * Prioritize foods rich in calcium, as well as vitamins A, B, and E.
In addition to the general well-being recommendations, the Clinical Pilates Group participated in a total of 16 face-to-face, clinically based Pilates exercise training sessions over eight weeks, with two sessions per week, each lasting 50 minutes. The exercise training started at the end of the menstrual cycle. The clinical Pilates-based exercise program applied to the group was designed by the researcher. The number of repetitions, levels, and variations of the exercises were progressively adjusted by the researcher according to the participants' conditions. During the first session, the principles of clinical Pilates were explained, following the BASI Pilates method as described by Isacowitz. Participants were taught alignment, breathing, and core engagement techniques.
Eligibility Criteria
You may qualify if:
- Having Premenstrual Syndrome (PMS)
- Being able to read and understand Turkish
- Willingness to participate in the study
You may not qualify if:
- Being in menopause or perimenopause
- Being pregnant
- Currently participating in or having engaged in a regular exercise program (other than clinical Pilates) within the past year
- Having comorbid orthopedic, musculoskeletal, psychological, or cardiovascular conditions that may affect test evaluations
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Atlas Universitylead
Study Sites (2)
Atlas University
Istanbul, Turkey (Türkiye)
Istanbul Atlas University
Istanbul, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Meltem Kaya
Atlas University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor Meltem Kaya
Study Record Dates
First Submitted
February 10, 2025
First Posted
February 19, 2025
Study Start
March 4, 2024
Primary Completion
December 30, 2024
Study Completion
February 1, 2025
Last Updated
February 19, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share